As reported (here) previously, Israel’s Biomica is developing microbiome therapies for antibiotic resistant bacteria. It is now partnering with the Weizmann Institute to develop a selective treatment against MRSA – antibiotic resistant strains of Staphylococcus aureus infection.

https://www.prnewswire.com/news-releases/biomica-to-collaborate-with-weizmann-institute-of-science-to-develop-a-selective-treatment-against-antibiotic-resistant-bacteria-300943752.html

https://www.biomicamed.com/